Linus Pauling's Scientific Legacy: The Chemical Bond to Molecular Disease

Table of Contents

  1. Overview
  2. The Nature of the Chemical Bond
  3. Protein Architecture: The Alpha Helix and Beta Sheet
  4. Sickle Cell Anemia: The First Molecular Disease
  5. The DNA Near-Miss
  6. Two Nobel Prizes
  7. The Turn to Vitamin C
  8. The Linus Pauling Institute Today
  9. How to Hold Both Paulings
  10. Key Research Papers
  11. Connections
  12. Featured Videos

1. Overview

Linus Pauling (1901–1994) is remembered on this site — and in most people's memories — as the Nobel laureate who spent his last three decades championing high-dose vitamin C. But that was his second career. Before the vitamin years, Pauling was arguably the most influential chemist of the twentieth century: the man who used the new physics of the 1920s to explain what a chemical bond actually is, who worked out the folding rules that all protein structures obey, and who showed — for the first time in history — that a disease could be traced to a single altered molecule. He remains the only person ever to win two unshared Nobel Prizes.

This page tells that mainstream half of his biography. It matters for two reasons. First, it is simply one of the great scientific stories: a boy from Portland, Oregon who rewrote the foundations of chemistry, structural biology, and medicine. Second, it explains something about the vitamin controversy that followed. When Pauling began making sweeping claims about vitamin C in the late 1960s, the world listened precisely because of the record described below. His authority was not manufactured — it was earned, at the highest level, over forty years. Understanding what he genuinely achieved is the only way to understand why his later claims commanded such attention, and why their eventual failure in controlled trials was such a hard lesson about the difference between brilliance and proof.

The arc runs like this: quantum mechanics applied to atoms (1920s–30s), the architecture of proteins (1948–51), the first molecular disease (1949), a famous public failure on DNA (1953), a Nobel Prize in Chemistry (1954), a Nobel Peace Prize (1962) — and then the turn to nutrition, which is covered on this hub's companion pages.

2. The Nature of the Chemical Bond

When Pauling began his career in the early 1920s, chemists knew perfectly well that atoms stick together to form molecules — they had been drawing bonds as little lines for half a century — but nobody could say why. What actually holds two atoms together? Why does carbon form four bonds and oxygen two? Why is water bent and carbon dioxide straight? The answers arrived with quantum mechanics, the new physics of electrons developed in Europe in 1925–27. Pauling, then a young Caltech PhD on a Guggenheim fellowship, went to Europe to learn it at the source — and became one of the first people on Earth to carry that physics back into chemistry.

Three of his ideas became so fundamental that they are now taught to every first-year chemistry student, usually without any sense of how strange they once were:

In 1939 he gathered this work into a book, The Nature of the Chemical Bond, which became one of the most-cited scientific works of the twentieth century and trained the generation of chemists who built modern molecular science. When the Nobel committee gave Pauling the 1954 Chemistry prize, it was for exactly this: his research into the nature of the chemical bond and its application to the structure of complex substances. The plain-language summary is worth stating: Pauling is a principal reason chemistry stopped being a catalog of recipes and became a science that explains and predicts.

3. Protein Architecture: The Alpha Helix and Beta Sheet

By the late 1930s Pauling had turned from simple molecules to the giant ones that run living things: proteins. A protein is a chain of amino acids — think of beads on a string — but a stretched-out chain does nothing. The chain must fold into a precise three-dimensional shape, and the shape is the machine. The question that stumped biology was: what shapes does the chain fold into, and what rules govern the folding?

Pauling attacked the problem in his characteristic way: get the small pieces exactly right first. Through the 1940s he and his Caltech colleague Robert Corey painstakingly measured the precise geometry of individual amino acids and small peptides with X-ray crystallography. Two facts emerged that became the keys. First, the peptide bond — the link between beads — is flat and rigid, a consequence of the resonance idea from section 2. Second, the folded chain should be stitched together by hydrogen bonds, weak attractions that act like small clips.

As Pauling later told the story, the breakthrough came in 1948 while he was in bed with a cold in Oxford: bored, he drew a chain of amino acids on a strip of paper and began folding the paper to see what the rigid-and-flexible geometry would allow. In 1951, with Corey and physicist Herman Branson, he published the answer: the alpha helix, a right-handed spiral staircase in which every turn is clipped to the next by hydrogen bonds, with about 3.6 amino acids per turn. That non-whole number was the masterstroke — competing groups had assumed a repeating structure must repeat in whole numbers, and nature simply doesn't. The same 1951 series of papers described the beta sheet (Pauling called it the pleated sheet): chains lying side by side like the folds of a paper fan, again held by hydrogen-bond clips.

These two shapes turned out to be the standard vocabulary of life. Nearly every protein structure ever solved — hemoglobin, antibodies, enzymes, the machinery read out by modern structure-prediction software — is described as an arrangement of alpha helices and beta sheets. The ribbon diagrams you see in any biology article, with their coiled springs and flat arrows, are drawings of Pauling's two structures. All of structural biology, and with it modern drug design, rests on the folding rules worked out in those 1951 papers.

4. Sickle Cell Anemia: The First Molecular Disease

Sickle cell anemia had been described clinically since 1910: in people with the disease, red blood cells collapse from smooth discs into stiff crescents — sickles — that jam small blood vessels, causing episodes of severe pain, anemia, and organ damage. By the 1940s doctors knew the disease ran in families and knew the cells sickled when oxygen was low. What nobody knew was why.

Pauling heard about the disease in 1945 — by his own well-documented account, from the hematologist William Castle during a train journey — and made a characteristic leap: if the red cell deforms, perhaps the problem lives in the cell's dominant molecule, hemoglobin, the protein that carries oxygen. Not a germ, not a toxin, not a failing organ — a single species of molecule, built slightly wrong.

To test it, his group — Harvey Itano, S. Jonathan Singer, and Ibert Wells — used electrophoresis, which is simpler than it sounds: dissolved molecules are placed in an electric field, and each molecule drifts at a speed set by its electric charge, so molecules with different charges literally migrate to different places. It is a racetrack that sorts molecules by charge. The result, published in Science in 1949 under the flatly revolutionary title “Sickle cell anemia, a molecular disease,” was clean: hemoglobin from sickle cell patients migrates differently from normal hemoglobin. Same protein, measurably different molecule. Strikingly, healthy carriers of the trait — people with one affected gene — showed a mixture of both hemoglobins, tying the altered molecule directly to inheritance.

Think about what that means: one wrong molecule, one disease — the way one misspelled word can change the meaning of a sentence. A few years later Vernon Ingram in Cambridge sharpened the point, showing that sickle hemoglobin differs from normal by a single amino acid out of hundreds. The entire field of molecular medicine descends from this result: newborn genetic screening, DNA diagnostics, the idea of designing a drug against a specific defective protein — all of it traces to the 1949 paper. In a fitting full-circle, sickle cell disease itself, the first molecular disease, became in 2023 one of the first diseases with an approved CRISPR gene-editing therapy.

One more thing descends from it, and this is the hinge of Pauling's whole biography: his conviction that health and disease are, at bottom, problems of molecules and their concentrations. If one wrong molecule can produce sickle cell anemia, why couldn't the right molecules, at the right concentrations, produce health? That is a genuinely powerful idea — and, stretched past the evidence twenty years later, it became the root of his megavitamin program. The triumph and the overreach grew from the same seed.

5. The DNA Near-Miss

By 1952 the biggest prize in biology was the structure of DNA, and most insiders assumed Pauling would claim it — he had just beaten the world to protein structure, using methods he had personally invented. In February 1953 he and Corey published their proposal in the Proceedings of the National Academy of Sciences: a triple helix, three chains wound together with the phosphate backbones packed at the core and the bases facing outward.

It was wrong — and wrong quickly. Critics immediately noted a startling chemical flaw: to make the tightly packed core work, the structure required DNA's phosphate groups to hold onto their hydrogens and carry no charge, yet DNA is an acid precisely because those groups give their hydrogens up. The structure, as drawn, was not really an acid at all — an elementary-seeming lapse from the century's greatest structural chemist. Pauling had also been working from older, lower-quality X-ray photographs; the sharp diffraction images being produced in London by Rosalind Franklin, which pointed to a two-chain structure with the phosphates on the outside, had never reached him. (His 1952 passport troubles, described in the next section, had kept him from a London scientific meeting; whether attending would have changed history is a debate for historians.) Within weeks, in April 1953, James Watson and Francis Crick published the double helix in Nature. Pauling conceded promptly and publicly — the double helix was clearly right, and he said so.

The episode is worth keeping on this page as an honesty anchor. Even at the absolute peak of his powers, Pauling could be spectacularly, publicly wrong — and fast. That is not a scandal; it is how science works, and his quick concession was the system functioning as designed. But hold onto the lesson, because it matters for the vitamin years: a great scientist's confident proposal is a hypothesis, not a result. In 1953 the field checked his claim against the evidence within weeks. In the 1970s, when the claims were about vitamin C and the audience was the general public, that checking took far longer — and reached a similar verdict.

6. Two Nobel Prizes

The 1954 Nobel Prize in Chemistry recognized the work of sections 2 and 3 — the nature of the chemical bond and its application to complex substances. Pauling received it alone, unshared, at the age of 53.

His second prize came from an entirely different kind of work. After Hiroshima, Pauling — strongly encouraged by his wife and lifelong political partner, Ava Helen Pauling — became one of the world's most prominent scientific voices against atmospheric nuclear weapons testing, arguing that radioactive fallout was quietly seeding cancers and birth defects worldwide and that no national interest justified it. In 1957–58 he organized a petition against nuclear testing that gathered signatures from more than eleven thousand scientists in dozens of countries, delivered to the United Nations in January 1958. The same year he laid out the case in his book No More War!

The activism carried a real price in McCarthy-era America. In 1952 the State Department denied Pauling a passport for travel to a scientific meeting in London, judging the trip contrary to the country's interests — the episode entangled, as noted above, with the DNA race. The passport was restored only shortly before he traveled to Stockholm for his 1954 Nobel ceremony. In 1960 he was summoned before a Senate internal-security subcommittee and, at real risk of a contempt citation, refused to name the people who had helped circulate his petition.

Vindication arrived with unusual theatrical timing. In October 1963, the Nobel committee announced that Pauling had won the Nobel Peace Prize for 1962 — on the very day the Partial Test Ban Treaty, the U.S.–U.K.–Soviet agreement ending atmospheric nuclear tests, entered into force. The cause he had been punished for had become international law. This prize, too, was unshared, which gives Pauling a distinction no one else in history holds: two Nobel Prizes, neither shared with anyone. (Marie Curie also won two Nobels, but her first was shared.)

7. The Turn to Vitamin C

The vitamin chapter began in the mid-1960s, after the biochemist Irwin Stone wrote to Pauling recommending gram-level daily doses of vitamin C; Pauling and his wife tried the regimen, felt dramatically better, and the world's most famous chemist became the world's most famous vitamin advocate. In 1968 he coined the word “orthomolecular” in a Science paper, and in 1973 he co-founded the institute that would become the Linus Pauling Institute, now at Oregon State University.

Those claims — and what happened when they met controlled trials — are stories for the sibling pages of this hub: Vitamin C and the Common Cold, Vitamin C and Cancer, Heart Disease and Lysine, and Orthomolecular Medicine, with the parallel story of his collaborator Dr. Abram Hoffer told on Hoffer's own page.

8. The Linus Pauling Institute Today

Pauling's institute outlived him and, in an outcome he might not have predicted, matured into a respected mainstream research center. Since 1996 the Linus Pauling Institute has been based at Oregon State University — fittingly, the school where Pauling did his undergraduate degree — studying micronutrients, aging, and disease prevention with conventional scientific methods.

Its most useful public offering is the Micronutrient Information Center: a free, extensively referenced, evidence-based encyclopedia of vitamins, minerals, and other dietary factors, written and reviewed by researchers and graded against the published clinical literature. It is one of the best places on the internet to check what the evidence actually says about any nutrient — and, tellingly, its measured conclusions sit far closer to ordinary dietary science than to its founder's gram-level dosing. The institute honors Pauling's question — what can nutrients do for health? — while answering it with the tool he sometimes skipped: controlled evidence.

9. How to Hold Both Paulings

Here is the uncomfortable, instructive truth: the man who founded molecular medicine and the man whose megavitamin claims failed their trials are the same man, using the same idea. “Disease is molecules at the wrong concentration” produced the sickle cell triumph in 1949 — and produced the vitamin C program twenty years later. The difference was never the brilliance of the hypothesis. The difference was what happened next. The sickle cell claim was tested against hard data immediately and confirmed at every step. The megavitamin claims went to the public first and to rigorous trials later — and when the trials came, they did not confirm the claims.

A few durable lessons fall out of holding both Paulings at once:

Read this way, Pauling's biography is not a fall from greatness into folly. It is a single, coherent career that accidentally ran the perfect experiment on the difference between genius and evidence — and left us both his molecules and his lesson.

10. Key Research Papers

  1. Pauling L, Itano HA, et al. Sickle cell anemia, a molecular disease. Science 1949;110(2865):543-8
  2. Pauling L, Corey RB, Branson HR. The structure of proteins; two hydrogen-bonded helical configurations of the polypeptide chain. Proc Natl Acad Sci USA 1951;37(4):205-11
  3. Pauling L, Corey RB. The pleated sheet, a new layer configuration of polypeptide chains. Proc Natl Acad Sci USA 1951;37(5):251-6
  4. Pauling L, Corey RB. A proposed structure for the nucleic acids. Proc Natl Acad Sci USA 1953;39(2):84-97
  5. Pauling L. Orthomolecular psychiatry. Varying the concentrations of substances normally present in the human body may control mental disease. Science 1968;160(3825):265-71
  6. Pauling L. The significance of the evidence about ascorbic acid and the common cold. Proc Natl Acad Sci USA 1971;68(11):2678-81

Live PubMed Searches

  1. Pauling and the chemical bond
  2. Pauling, Corey, Branson and the alpha helix
  3. Sickle hemoglobin electrophoresis and molecular disease
  4. Pauling and the history of molecular disease
  5. Pauling and ascorbic acid

Connections

Back to Table of Contents